ARTICLE | Company News
Eurocept, NordMedica A/S deal
February 18, 2013 8:00 AM UTC
Specialty pharma Eurocept acquired cancer company NordMedica. NordMedica has worldwide rights to amsacrine, which is marketed as Amekrin, Amsidine and Amsidyl to treat acute myeloid leukemia (AML) and...